Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, g-lactone,(17a)-

CAS: 976-71-6

Ref. IN-DA00IJYM

Produktinformation

• Name: Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, g-lactone,(17a)-
• Synonyme: [u'11614 R.P.', u'Aldadiene', u'Canrenone', u'Phanurane', u'R.P., 11614', u'SC 9376', u'SC-9376', u'SC9376', u'CANRENONE', u'976-71-6', u'Aldadiene', u'Phanurane', u'Luvion', u'Aldadiene (VAN)', u'Canrenone [USAN:INN]', u'Canrenonum [INN-Latin]', u'Canrenona [INN-Spanish]', u'UNII-78O20X9J0U', u'SC-9376', u'EINECS 213-554-5', u'NSC 261713', u'BRN 0046602', u'11614 R.P', u'78O20X9J0U', u'MFCD00071735', u'17alpha-(2-Carboxyethyl)-17beta-hydroxyandrosta-4,6-dien-3-one lactone', u'17-Hydroxy-3-oxo-17alpha-pregna-4,6-diene-21-carboxylic acid gamma-lactone', u'DSSTox_CID_25930', u'DSSTox_RID_81231', u'DSSTox_GSID_45930', u'Canrenonum', u'Canrenona', u'Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, gamma-lactone (17alpha)-', u"(8R,9S,10R,13S,14S,17R)-10,13-dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,5'-oxolane]-2',3-dione", u'CAS-976-71-6', u'SMR000539206', u'11614 R. P.', u'20-Spiroxa-4,6-diene-3,21-dione', u'NCGC00095148-01', u"(8R,9S,10R,13S,14S,17R)-10,13-dimethyl-1,8,9,10,11,12,13,14,15,16-decahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H,4'H)-dione", u'Canrenone (USAN)', u'EC 213-554-5', u'AC1L22HH', u'SCHEMBL19560', u'5-17-11-00476 (Beilstein Handbook Reference)', u'MLS001163777', u'MLS001304014', u'MLS001304154', u'Canrenone, >=97% (HPLC)', u'CHEMBL1463345', u'DTXSID3045930', u'Spironolactone Related Compound A', u'CHEBI:135445', u'UJVLDDZCTMKXJK-WNHSNXHDSA-N', u'HMS2090K21', u'HMS2870D16', u'HMS3715A05', u'BCP10925', u'HY-B1438', u'ZINC3881648', u'Tox21_111451', u'BBL010921', u'STK801874', u'AKOS005622473', u'Tox21_111451_1', u'AC-1323', u'CCG-220962', u'DB12221', u'MCULE-8218872905', u'NE40132', u'SC14266', u'Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, gamma-lactone, (17alpha)-', u'NCGC00263479-01', u'NCGC00263479-02', u'AJ-46645', u'AK-77478', u'AS-13160', u'H489', u'RP-11614', u'SC-15111', u'AB0013073', u'LS-118413', u'11614 R. P', u'6,7-Dehydro-7|A-desthioacetylspironolactone', u'B7341', u'CS-0013142', u'D03363', u'J10438', u'AB00825212-04', u'AB00825212-06', u'976C716', u'SR-01000813823', u'SR-01000813823-2', u'17b-Hydroxy-3-oxopregna-4,6-diene-21-carboxylic acid', u'Z1563146205', u'Canrenone, European Pharmacopoeia (EP) Reference Standard', u'17-Hydroxy-3-oxo-17a-pregna-4,6-diene-21-carboxylic acid lactone', u'17|A-2-Carboxyethyl-17|A-hydroxyandrosta-4,6-dien-3-one Lactone', u'17a-(2-Carboxyethyl)-17b-hydroxyandrosta-4,6-dien-3-one lactone', u'(17?)-17-Hydroxy-3-oxopregna-4,6-diene-21-carboxylic acid ?-lactone', u'(17|A)-17-Hydroxy-3-oxo-pregna-4,6-diene-21-carboxylic Acid |A-Lactone', u'17-Hydroxy-3-oxo-17a-pregna-4,6-diene-21-carboxylic acid g-lactone', u"3'-(3-Oxo-17b-hydroxyandrosta-4,6-dien-17a-yl)-propionic acid lactone", u'3-(17b-Hydroxy-3-oxoandrosta-4,6-dien-17a-yl)propionic acid g-lactone', u'3-(17b-Hydroxy-3-oxoandrosta-4,6-dien-17a-yl)propionic acid lactone', u'3-(3-Oxo-17b-hydroxy-4,6-androstadien-17a-yl)propionic acid g-lactone', u"(2'R)-3',4'-Dihydro-5'H-spiro[androst-4,6-diene-17,2'-furan]-3,5'-dione (Canrenone)"], (10R,13S,17R)-10,13-dimethyl-1,8,9,10,11,12,13,14,15,16-decahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H,4'H)-dione, (8R,9S,10R,13S,14S,17R)-10,13-dimethyl-1,8,9,10,11,12,13,14,15,16-decahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H,4'H)-dione, 10,13-dimethyl-1,8,9,10,11,12,13,14,15,16-decahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H,4'H)-dione, 11614 R. P., 17-Hydroxy-3-oxo-17alpha-pregna-4,6-diene-21-carboxylic acid gamma-lactone, 17-Hydroxy-3-oxo-17α-pregna-4,6-diene-21-carboxylic acid lactone, 17-Hydroxy-3-oxo-17α-pregna-4,6-diene-21-carboxylic acid γ-lactone, 17alpha-(2-Carboxyethyl)-17beta-hydroxyandrosta-4,6-dien-3-one lactone, 17alpha-Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, gamma-lactone (8CI), 17α-(2-Carboxyethyl)-17β-hydroxyandrosta-4,6-dien-3-one lactone, 17α-Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, γ-lactone, 17β-Hydroxy-3-oxopregna-4,6-diene-21-carboxylic acid, 20-Spiroxa-4,6-diene-3,21-dione, 3-(17β-Hydroxy-3-oxoandrosta-4,6-dien-17α-yl)propionic acid lactone, 3-(17β-Hydroxy-3-oxoandrosta-4,6-dien-17α-yl)propionic acid γ-lactone, 3-(3-Oxo-17β-hydroxy-4,6-androstadien-17α-yl)propionic acid γ-lactone, 3′-(3-Oxo-17β-hydroxyandrosta-4,6-dien-17α-yl)-propionic acid lactone, Aldadiene, Aldadiene (VAN), Brn 0046602, Canrenona, Canrenona [INN-Spanish], Canrenone [USAN:INN], Canrenonum, Canrenonum [INN-Latin], Luvion, Nsc 261713, Phanurane, Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, gamma-lactone (17alpha)-, Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, γ-lactone, (17α)-, Rp 11641, Sc 9376, Spiro[17H-cyclopenta[a]phenanthrene-17,2′(5′H)-furan], pregna-4,6-diene-21-carboxylic acid deriv., Spirolactone SC 14266, Unii-78O20X9J0U, Canrenone
• Marke: Indagoo

Chemische Eigenschaften

• Molekulargewicht: 340.4559
• Formel: C₂₂H₂₈O₃
• Reinheit: 98%
• Farbe/Form: Solid
• InChl: InChI=1S/C22H28O3/c1-20-9-5-15(23)13-14(20)3-4-16-17(20)6-10-21(2)18(16)7-11-22(21)12-8-19(24)25-22/h3-4,13,16-18H,5-12H2,1-2H3/t16-,17+,18+,20+,21+,22-/m1/s1
• InChI Key: UJVLDDZCTMKXJK-WNHSNXHDSA-N